RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced that Andres Isaias, its Chief ...

The move will enable the company to strengthen its foothold in the US and establish its presence in the fast-growing global ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

PharmAla has granted the Multidisciplinary Association for Psychedelic Studies (MAPS) authorization to post the PharmAla LaNeo MDMA Investigator’s Brochure (IB) publicly on the MAPS website. Access to ...

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...

Scotland’s biotechnology sector is celebrating a major milestone with the launch of the nation’s first open-access 300-liter ...

By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...

The new data shows there were some 143,000 life science jobs in 2024, an increase of just 0.03% from 2023, according to the ...

STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Cellular Highways ...

BEAM Circular and the San Joaquin County Office of Education are teaming up to host two programs this month at the Durham ...

Stricken drug developers Opthea and Patrys have reported in from biotech's 'death zone', where they're running low on oxygen.